Cite
Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report.
MLA
Intapiboon, Porntip, et al. “Humoral Immunogenicity of MRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 NCoV-19 or Homologous ChAdOx1 NCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report.” Vaccines, vol. 11, no. 3, Mar. 2023, p. 537. EBSCOhost, https://doi.org/10.3390/vaccines11030537.
APA
Intapiboon, P., Pinpathomrat, N., Juthong, S., Uea-Areewongsa, P., Ongarj, J., & Siripaitoon, B. (2023). Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report. Vaccines, 11(3), 537. https://doi.org/10.3390/vaccines11030537
Chicago
Intapiboon, Porntip, Nawamin Pinpathomrat, Siriporn Juthong, Parichat Uea-Areewongsa, Jomkwan Ongarj, and Boonjing Siripaitoon. 2023. “Humoral Immunogenicity of MRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 NCoV-19 or Homologous ChAdOx1 NCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report.” Vaccines 11 (3): 537. doi:10.3390/vaccines11030537.